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ABSTRACT.
The asymmetric synthesis of a series of iodinated P-adrenoceptor ligands is described. With respect to the imaging of P-adrenergic receptors, until now only a few radioligands have been synthesized with either "C or 'sF for PET. The P-adrenoceptor antagonist S-CGP12177 (4(3-t-butylamino-2-hydroxypropoxy)benzimidazol-2-one (l-3) has been labelled successfully with "C, but the specific activity of this radioligand was rather low (400 to 1300 mCi/p,mol) (2-4). More recently, the P-adrenoceptor antagonist carazolol has been labelled successfully with 'sF and/or "C (5-8).
Using this tracer, the P-adrenergic receptor population could be clearly visualized in the human heart.
One of the major advantages of SPECT over PET is that the isotopes used in SPECT, such as 1231, have a significant longer half-life than do the isotopes used in PET (hours vs. minutes), thus allowing a substantial longer acquisition time in SPECT. Several investigators (9, 10) have studied the possible use of ['231]iodocyanopindolol as a radioligand; however, this compound also displayed considerable affinity for serotonergic receptors. CGP12177 is a potent hydrophilic P-adrenoceptor antagonist. Therefore, we recently synthesized two iodinated analogues of CGP12 177 (11) as a radioligand for the imaging of P-adrenoceptors using SPECT. These two analogues were iodinated at the phenyl part of the molecule.
Although one of the two analogues showed reasonable affinity for the P-adrenoceptor, a high nonspecific binding in viwo was observed.
In the present study, both the synthesis and the characterization of a few new analogues of S-CGP12177 are described where the iodine is positioned in the alkylamino group of the molecule. In addition, the synthesis of an iodine-containing compound with a high stereochemical resemblance to the nonselective, high-affinity P-adrenoceptor antagonist penbutolol is described. In Fig. 1 
Synthesis of CYBL4A
( Fig. 3) The first four steps of the synthesis are similar to the first four steps of the synthesis of CYBL4E (Fig. 3) . After 2 h, 0.5 mL 1 M KF and 0.5 mL 1 M NaHSO, were added, and the resulting mixture was stirred vigorously. Two separate layers emerged. The aqueous layer was diluted with MeOH.
The white precipitate formed was removed by filtration. The filtrate was concentrated and purified by chromatography on silica with EtOAc:MeOH (9:l) to give 9 mg CYBL4A (85%). 'H NMR (CDCl,:CD,OD = 9:l): 6 6.95 (t, J = 7.9 Hz, lH), 6.75 Synthesis of CYBL6 (Fig. 4) 4dODOBENZYLAMINE.
An amount of 600 mg (2 mmol) 4-iodobenzyl bromide (14) was stirred in 10 mL 7 M NH, in methanol for 5 days at room temperature.
The mixture was thereafter concen-trated, and to the residue a solvent mixture of 60 mL CHCl, and water (2:l) was added. Subsequently, NazCO, was added, followed by vigorous shaking.
The organic layer was dried on Na,S04 and concentrated, to yield 400 mg 4-iodobenzylamine (85%). aryl nitro derivative 5c in 10 mL EtOH was added 600 mg (2.7 mmol)
SnCl, * 2Hz0, and this mixture was stirred for 5 h at 80°C.
Then it was concentrated in wacuo and dissoved in 20 mL 2 N HCl.
The flask was cooled in ice, and 2 mL of 1.93 M COCl, in toluene was added to the vigorously stirred solution.
The resulting mixture was stirred overnight, which resulted in crystallization. In the present study, the synthesis of a number of new iodinated ligands is described. Based on penbutolol we designed CYBL3. Replacement of the cyclopentyl group of penbutolol for an iodine atom resulted in CYBW, which is one of the simplest members of the class of phenoxypropanolamines possessing the essential elements for binding to the P-adrenoceptor and an iodine atom.
Finally, the new N-iodoalkyl analogues of CGP12177 can be subdivided in iodovinyl compounds (Fig. 2) and an iodoaryl derivative (CYBL6). The radiolabelled forms of these compounds are readily available by oxidative iododestannylation, which resulted in compounds with a high specific activity.
